Despite advances in diagnostic criteria, the accurate diagnosis of CIDP remains challenging due to persistent controversies regarding electrodiagnostic parameters, disease boundaries with anti-MAG antibody neuropathy, and the recognition of patients who do not meet formal criteria yet respond to treatment. This evidence concerns the gene MAG and chronic inflammatory demyelinating polyradiculoneuropathy.